Impact of HPV mRNA types 16, 18, 45 detection on the risk of CIN3+ in young women with normal cervical cytology.

Khalid Al-ShibliHiba Abdul Latif MohammedRamona MaursethMikkel FostervoldSebastian WernerSveinung Wergeland Sørbye

Published in: PloS one (2022)

By testing women 25-39 years of age with a normal cytology result using a specific 3-type HPV mRNA test, an increase in screening programme sensitivity can be achieved without an excessive additional workload. Women with normal cytology and a negative HPV mRNA test have a very low risk of cervical cancer.

Keyphrases

high grade
fine needle aspiration
cervical cancer screening
binding protein
ultrasound guided
polycystic ovary syndrome
type diabetes
clinical trial
study protocol
pregnant women
physical activity
metabolic syndrome
middle aged
body mass index
skeletal muscle
adipose tissue